title: Efficacy and safety of saxagliptin as add-on therapy in type 2 diabetes.
abstract: Combination therapy for type 2 diabetes using agents with complementary mechanisms of action may improve glycemic control to a greater extent than monotherapy and allow the use of lower doses of antihyperglycemic medications. Dipeptidyl peptidase-4 inhibitors, including saxagliptin, are recommended as add-on therapy to metformin and as part of two- or three-drug combinations in patients not meeting individualized glycemic goals with metformin alone or as part of a dual-therapy regimen. This article reviews the efficacy and safety of saxagliptin as an add-on therapy to metformin, glyburide, a thiazolidinedione, or insulin (with or without metformin) and as a component of triple therapy with metformin and a sulfonylurea.
authors: Joshua J
authors: JJ
authors: Neumiller
references: Diabetes Care. 2005 Dec;28(12):2901-7
references: 16306552
references: N Engl J Med. 2013 Oct 3;369(14):1317-26
references: 23992601
references: Diabetes Care. 2009 Sep;32(9):1649-55
references: 19478198
references: Diabetes Care. 2004 Jan;27 Suppl 1:S84-7
references: 14693935
references: J Clin Invest. 2007 Jan;117(1):24-32
references: 17200703
references: Int J Clin Pract. 2011 Dec;65(12):1230-9
references: 21977965
references: Diabetes Care. 2009 Nov;32 Suppl 2:S151-6
references: 19875543
references: Diabetes Care. 2004 Jul;27(7):1535-40
references: 15220224
references: Curr Med Res Opin. 2009 Aug;25(8):1985-93
references: 19555311
references: J Am Coll Nutr. 2003 Oct;22(5):331-9
references: 14559925
references: Ann Intern Med. 2011 May 3;154(9):602-13
references: 21403054
references: Curr Med Res Opin. 2012 Apr;28(4):513-23
references: 22313154
references: Clin Ther. 2006 Oct;28(10):1556-68
references: 17157112
references: Diabetes Care. 2012 Jun;35(6):1364-79
references: 22517736
references: Diabetes Care. 2004 Jun;27(6):1487-95
references: 15161807
references: Diabetes. 2009 Apr;58(4):773-95
references: 19336687
references: Am J Kidney Dis. 2012 Jan;59(1 Suppl 1):A7, e1-420
references: 22177944
references: Arch Intern Med. 2004 Jul 12;164(13):1422-6
references: 15249351
references: Diabetes Care. 2007 Jun;30(6):1374-83
references: 17363746
references: Diabetes Obes Metab. 2011 Jul;13(7):604-14
references: 21332626
references: Int J Clin Pract. 2010 Nov;64(12):1619-31
references: 20846286
references: Clin Pharmacokinet. 2011 Apr;50(4):253-65
references: 21348538
references: J Clin Endocrinol Metab. 2009 Dec;94(12):4810-9
references: 19864452
references: Diabetes Care. 2005 Apr;28(4):956-62
references: 15793206
references: Int J Clin Pract. 2010 Jul;64(8):1121-9
references: 20236369
references: Cardiovasc Diabetol. 2012 Jan 16;11:6
references: 22248301
references: Diabetes Obes Metab. 2011 Jun;13(6):523-32
references: 21332627
references: Cardiovasc Diabetol. 2012 Jan 10;11:3
references: 22234149
references: Am J Kidney Dis. 2007 Feb;49(2 Suppl 2):S12-154
references: 17276798
references: Int J Clin Pract. 2009 Sep;63(9):1395-406
references: 19614786
references: N Engl J Med. 2013 Oct 3;369(14):1327-35
references: 23992602
references: JAMA. 2007 Jul 11;298(2):194-206
references: 17622601
references: Clin Pharmacol. 2011;3:13-25
references: 22287853
references: Circulation. 2008 Apr 15;117(15):1945-54
references: 18378618
references: Diabetes Obes Metab. 2011 Jun;13(6):567-76
references: 21342412
references: Diab Vasc Dis Res. 2011 Apr;8(2):150-9
references: 21562067
references: Nephrol Dial Transplant. 2009 Feb;24(2):338-41
references: 19015168
references: Curr Med Res Opin. 2009 Oct;25(10):2361-71
references: 19650752
references: BMC Endocr Disord. 2010 Apr 22;10:7
references: 20412573
references: Lancet. 2006 Nov 11;368(9548):1696-705
references: 17098089
references: Diabet Med. 2013 Dec;30(12):1472-6
references: 23802840
references: Diabetes Care. 2004 Aug;27(8):2067-73
references: 15277443
references: Diab Vasc Dis Res. 2011 Apr;8(2):125-35
references: 21562064
references: Diabetes Obes Metab. 2009 Jun;11(6):611-22
references: 19515181
references: Diabetes Obes Metab. 2010 Jun;12(6):485-94
references: 20518804
references: Curr Med Res Opin. 2009 Oct;25(10):2401-11
references: 19650754
references: Br J Clin Pharmacol. 2011 Jul;72(1):92-102
references: 21651615
references: Postgrad Med. 2010 May;122(3):16-27
references: 20463410
references: Diabetes Care. 2008 Feb;31 Suppl 2:S125-30
references: 18227472
references: Drug Metab Dispos. 2012 Jul;40(7):1345-56
references: 22496391
references: JAMA. 1999 Jun 2;281(21):2005-12
references: 10359389
references: N Engl J Med. 2006 Dec 7;355(23):2427-43
references: 17145742
references: JAMA. 2010 Apr 14;303(14):1410-8
references: 20388897